Skip to main content
. Author manuscript; available in PMC: 2019 Oct 16.
Published in final edited form as: Immunity. 2018 Oct 16;49(4):754–763.e4. doi: 10.1016/j.immuni.2018.09.016

Figure 1. Stinggt/gt mice are susceptible to tumors independently of effects on T and B cells.

Figure 1.

Tumor cells were injected s.c. into mice (n=4-6). Tumor growth was assessed by caliper measurements, and statistical significance was assessed by 2-way ANOVA. Bars represent +/− means SEM. Results are representative of two to four independent experiments. Tumors were injected into WT or Stinggt/gt mice (A, C), into WT or Irf3−/− mice (B, D), or into Rag2−/− or Rag2−/− Stinggt/gt mice (E,F,G). The mice were injected with the following tumor doses: (A, B, E) 2 × 105 RMA-S or RMA cells; (C, D, F) 2 × 104 B16-BL6 cells; (F) 5 × 104 RMA-RAE-1ε cells; (G) 105 MC38 cells